United States · Platforms & data · MarketBeat

HC Wainwright Issues Positive Forecast for Spyglass Pharma (NASDAQ:SGP) Stock Price

Published by MarketBeat · United States 57 min ago

Image from MarketBeat Media, LLC. · MarketBeat

Detailed summary

HC Wainwright lifted their price target on shares of Spyglass Pharma from $37.00 to $43.00 and gave the stock a "buy" rating in a research note on Thursday.

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

The Motley Fool

Nvidia CEO Jensen Huang Says AI's 'Most Profound Impact' Will Be in Life Sciences -- and Eli Lilly Is Already Building on It

MarketWatch

I inherited $1.4 million from my father. Am I wrong to ask my husband of 25 years for a postnuptial agreement?

Seeking Alpha

Altimmune outlines $480M cash runway through 2029 PERFORMA readout as RESTORE data targeted for 2H 2027

CNBC

Oil prices rise after Trump says no Iran deal needed: 'We've got their Strait'

Investing.com

Grupo Equatorial Q3 2026 slides: EBITDA rises amid debt pressures

Benzinga